Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene

p53: A new player in reproduction

(2010) Wenwei Hu et al.   CELL CYCLE

Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma

(2009) E. F. Firoz et al.   CLINICAL CANCER RESEARCH

Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?

(2009) Mark Wade et al.   MOLECULAR CANCER RESEARCH

Impact ofMDM2single nucleotide polymorphism on tumor onset in head and neck squamous cell carcinoma

(2008) Masashi Nakashima et al.   ACTA OTO-LARYNGOLOGICA

MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

(2008) Y. J. Yoon et al.   CARCINOGENESIS

Both Germ Line and Somatic Genetics of the p53 Pathway Affect Ovarian Cancer Incidence and Survival

(2008) F. Bartel et al.   CLINICAL CANCER RESEARCH

MDM2 SNP309 Is Associated With Poor Outcome in B-Cell Chronic Lymphocytic Leukemia

(2008) Irina Gryshchenko et al.   JOURNAL OF CLINICAL ONCOLOGY

The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme

(2008) Rina G. Khatri et al.   JOURNAL OF NEUROSURGERY

A complex barcode underlies the heterogeneous response of p53 to stress

(2008) Fiona Murray-Zmijewski et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33

(2008) B. Gold et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA